- ISIN
- US09060C4087
- CUSIP
- 09060C408
- Sector
- Industrials
- Industry
- Security & Protection Services
- IPO Date
- Feb 14, 1997
Highlights
- Market Cap
- $36.24M
- Enterprise Value
- $33.63M
- EPS (TTM)
- -$0.63
- Total Revenue (TTM)
- $6.10M
- Gross Profit (TTM)
- $4.72M
- EBITDA (TTM)
- -$4.10M
- Year Range
- $3.10 - $19.70
- ROA (TTM)
- -42.25%
- ROE (TTM)
- -59.86%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BKYI Performance Chart
BIO-key International, Inc. (BKYI) is down 27.7% since the beginning of the year. At $4 per share, BKYI is trading 80.2% below its 52-week high of $20. Investors who bought $1,000 worth of BKYI shares 5 years ago would now be looking at an investment worth $6.
Loading charts...
Returns By Period
BIO-key International, Inc. (BKYI) has returned -27.66% so far this year and -51.89% over the past 12 months. Over the last ten years, BKYI has returned -50.95% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
BIO-key International, Inc.
- 1D
- 2.63%
- 1M
- -17.89%
- YTD
- -27.66%
- 6M
- -38.11%
- 1Y
- -51.89%
- 3Y*
- -69.04%
- 5Y*
- -64.62%
- 10Y*
- -50.95%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
BKYI Monthly Returns History
Based on dividend-adjusted daily data since Feb 21, 2002, BKYI's average daily return is +0.08%, while the average monthly return is -0.38%.
Historically, 40% of months were positive and 60% were negative. The best month was Jan 2009 with a return of +131.6%, while the worst month was Oct 2023 at -63.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, BKYI closed higher 38% of trading days. The best single day was Mar 11, 2020 with a return of +140.8%, while the worst single day was Mar 12, 2020 at -35.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 34.58% | -9.81% | -18.98% | -5.87% | -9.36% | -13.77% | -27.66% | ||||||
| 2025 | -21.64% | -24.63% | -21.88% | 1.95% | 4.43% | -2.68% | -5.82% | -2.52% | -4.09% | 8.36% | 3.63% | -33.30% | -68.47% |
| 2024 | -33.33% | 5.00% | 0.00% | -21.43% | 17.79% | -15.62% | -11.58% | -8.28% | -27.86% | 37.57% | -31.82% | 90.00% | -43.00% |
| 2023 | 40.15% | -10.98% | -4.11% | -5.71% | 18.18% | -3.62% | -6.76% | -27.25% | 5.86% | -62.99% | 7.61% | -22.48% | -71.51% |
| 2022 | -0.90% | 0.91% | 8.60% | -11.25% | -12.68% | -4.84% | 1.69% | -5.56% | -10.00% | 1.96% | -40.38% | -37.09% | -73.52% |
| 2021 | 10.23% | 5.15% | -14.46% | -1.15% | 16.81% | -5.71% | -15.79% | -1.25% | 11.39% | -9.94% | -22.40% | -10.16% | -37.22% |
Benchmark Metrics
BIO-key International, Inc. has an annualized alpha of 20.56%, beta of 0.18, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 21, 2002.
- This stock participated in 168.93% of S&P 500 Index downside but only -8.43% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.18 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 20.56%
- Beta
- 0.18
- R²
- 0.00
- Upside Capture
- -8.43%
- Downside Capture
- 168.93%
Return for Risk
Risk / Return Rank
BKYI ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for BIO-key International, Inc. (BKYI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BKYI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.52 | ||
| Sortino ratioReturn per unit of downside risk | -3.08 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.37 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | 2.78 | -3.57 |
| Martin ratioReturn relative to average drawdown | -1.51 | 12.44 | -13.95 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the BIO-key International, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BIO-key International, Inc. was 100.00%, occurring on May 12, 2026. The portfolio has not yet recovered.
The current BIO-key International, Inc. drawdown is 100.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -100.00%May 2026 | 22y 27d | — | 22y 2moApr 2004 - now |
Dot-com crash2000–2002 | -74.76%Aug 2002 | 6mo 2d | 1y 3mo | 1y 9moFeb 2002 - Dec 2003 |
2004 bear market2004 | -30.56%Mar 2004 | 1mo 12d | 15d | 1mo 27dJan 2004 - Mar 2004 |
2003 bear market2003 | -22.14%Dec 2003 | 15d | 14d | 29dDec 2003 - Jan 2004 |
2004 correction2004 | -12.50%Mar 2004 | 4d | 8d | 12dMar 2004 - Apr 2004 |
Drawdown Indicators
| BKYI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -66.41% | -9.10% | -57.31% |
Max Drawdown (3Y)Largest decline over 3 years | -97.54% | -18.90% | -78.64% |
Max Drawdown (5Y)Largest decline over 5 years | -99.52% | -25.43% | -74.09% |
Max Drawdown (10Y)Largest decline over 10 years | -99.93% | -33.92% | -66.01% |
Current DrawdownCurrent decline from peak | -100.00% | -1.80% | -98.20% |
Average DrawdownAverage peak-to-trough decline | -88.55% | -10.71% | -77.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.32% | 2.03% | +32.29% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of BIO-key International, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how BIO-key International, Inc. is priced in the market compared to other companies in the Security & Protection Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BKYI relative to other companies in the Security & Protection Services industry. Currently, BKYI has a P/S ratio of 4.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BKYI in comparison with other companies in the Security & Protection Services industry. Currently, BKYI has a P/B value of 4.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BKYI
Add BIO-key International, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BKYI